Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891839-19-000038
Filing Date
2019-03-18
Accepted
2019-03-18 16:30:54
Documents
1
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 12533
  Complete submission text file 0000891839-19-000038.txt   14336
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
FRIEDBERG ALBERT (Reporting) CIK: 0001268239 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38624 | Film No.: 19688627

Mailing Address 44 WOODLAND ROAD PITTSFORD NY 14534
Business Address 44 WOODLAND ROAD PITTSFORD NY 14534 585-271-2827
Vaccinex (Rochester), L.L.C. (Reporting) CIK: 0001747866 (see all company filings)

State of Incorp.: GA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38624 | Film No.: 19688626